Denali Therapeutics
DNLI
DNLI
78 hedge funds and large institutions have $1.46B invested in Denali Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 8 closing their positions.
Holders
78
Holders Change
+11
Holders Change %
+16.42%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
19
Increased
38
Reduced
11
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$186K
Top Buyers
| 1 |
1
BlackRock
New York
|
$71.9M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$105M |
| 3 |
3
Lord, Abbett & Co
Jersey City,
New Jersey
|
$24.5M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$19.4M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$15.4M |
